絞り込み

17696

広告

Immunotherapy in melanoma.

著者 Mitchell TC , Feld E
Immunotherapy.2018 Aug ; 10(11):987-998.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (16view , 0users)

Full Text Sources

Medical

Immunotherapy has dramatically improved the prognosis for patients with melanoma and has become the cornerstone of treatment for those with advanced disease. The role of immunotherapy continues to expand with multiple new agents approved in the adjuvant as well as metastatic setting, as first-line therapy and beyond. We review the currently approved drugs for the treatment of melanoma, along with clinical trial data, adverse side effects, response assessment and future directions.
PMID: 30149766 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード